Results of CCK8 cell viability assay revealed that proliferative capacity of two DLBCL cells was enhanced after SMIT1 overexpression, yet inhibited after SMIT1 silencing (Fig. 2B). This evidence concerns the gene SLC5A3 and diffuse large B-cell lymphoma.